Contact us for a demo Follow us:
Time flies like an arrow…
40 years have gone by since I graduated, 30 years since I created Novasep and 10 years since I created Ypso-Facto. At Ypso-Facto, during the last years we built simulation-based software taking the difficult path of mechanistic modeling. No matter the challenges, we have stayed true to our belief...
Bioprocess Development Symposium Celebrating Ypso-Facto’s 10th Anniversary
2-3 October 2024, Nancy
On October 2-3 2024, Ypso-Facto marked a significant milestone by hosting the Bioprocess Development Symposium in celebration of its 10th anniversary. This two-day event, held in Nancy, France, brought together industry leaders and innovators to explore the cutting edge of bioprocessing. The...
Ypso-Facto are pleased to announce that they got granted three families of patents
Ypso-Facto are pleased to announce that they got granted three families of patents in the last months: Method and device for simulating an industrial facility for exploiting a chemical or biochemical method EP 3 566 769 B1 System and method for simulating chemical or biochemical process EP...Ypso-Facto cooperates with SmarSEP Industries to provide process modeling and numerical simulation services for the Chinese Industrial Biotechnology Market.
Ypso-Facto® (Nancy, France), a leading provider of (bio)chemical process simulation software and services, has announced a cooperation agreement with Shanghai- based SmarSEP Industries to provide process modeling and numerical simulation services for the Chinese Industrial Biotechnology Market...
Ypso-Facto officially joins the ACCESS project
Ypso-Facto is proud to join officially the ACCESS project (Advanced Cell Control by Spectroscopic Sensors), a French R&D project aiming at improving the production of Advanced Therapy Medicinal products. This project is led by INDATECH – Chauvin Arnoux group, gathers MTInov , StemInov ...
PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!
Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.
Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation , Ypso-Facto will develop software solutions to support production of innovative therapies. The company will work on...
CALIPSO: revolutionizing the management of bioproduction processes in healthcare
Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !
A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence...
Introducing the 2021 update of Ypso-Ionic, the software solution for designing chromatographic processes
Including ion exchange, adsorption, affinity, hydrophobic interactions, size exclusion, ion exclusion, chelation...
We are delighted to introduce the latest version of Ypso-Ionic ® - 2021edition. Ypso-Ionic is the first commercial application of the Proxima software suite! Maximize the value of your data Embrace the power of mechanistic simulation Open up a new world of opportunities for...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
Download
© Ypso-Facto 2014 - Powered by Ealys | Legal Information